Pharma vs Semiconductor HEPA/ULPA Filter Inputs

Share By:

A pharmaceutical facility manager and a semiconductor fab engineer can request a filter with the same nominal efficiency rating and still be specifying two entirely different things. The question that matters before either one writes an RFQ is not which filter class to name, but which process risk the filter exists to control — because that answer determines what evidence, interface, and qualification data belong in the brief before a supplier can return a meaningful quotation.

The Process Risks That Set Each Sector’s Filter Inputs

SectorRequirement set starts withDistinctions to preserveSystem inputs that affect the filter brief
PharmaceuticalProcess, product exposure, contamination-control strategy, room-grade context, and qualification lifecycleDo not translate an EU GMP grade into an ISO airborne-particle classInstalled filter, airflow, pressure, airflow visualization, and recovery qualification, as applicable to the grade, equipment function, risk, and standards
SemiconductorAirborne-particle classification, chemical-contamination risks, tool heat loads, recirculation strategy, and service accessKeep particle classification and airborne chemical cleanliness on separate requirement basesTool heat loads, recirculation strategy, airflow integration, and service access

A filter specification only makes sense once the reader knows what it is protecting against, and the two sectors are rarely protecting against the same thing. In pharmaceutical manufacturing, the filter input sheet starts from the process itself: what is exposed, at what stage, and what the contamination-control strategy for that stage requires. The filter is one control point inside a room-grade context that already carries its own qualification lifecycle. In semiconductor manufacturing, the filter input sheet starts from a different question: what is the airborne-particle classification the process tool needs, and separately, is there a chemical-contamination risk that a particle filter cannot address at all.

This difference changes what “requirement” means in each case. Where a pharmaceutical process depends on sterility assurance or bioburden control, the relevant evidence is tied to the room grade and to the stage of qualification the facility has reached — installed filter integrity, airflow, pressure differential, airflow visualization, and recovery testing all belong to that lifecycle, and which of them applies depends on the grade, the equipment’s function, and the risk being managed. Where a semiconductor process depends on a tool’s sensitivity to particle deposition, the same filter question has to be answered against an airborne-particle classification, and if the tool or process also carries a risk from airborne molecular contamination, that risk sits on an entirely separate basis that a particle-rated filter does not resolve.

The consequence for the buyer is that naming a filter class first, before establishing which of these risk bases applies, produces a specification that looks complete but is not anchored to anything. A filter chosen only against an efficiency number may satisfy a particle count and still miss a chemical-contamination exposure the process actually has, or may be procured without the qualification data a pharmaceutical room grade will require at handover. Confirming the process risk first — product exposure and room grade for pharmaceutical projects, particle classification separated from chemical risk for semiconductor projects — is what allows the rest of the input sheet to be built correctly rather than retrofitted later.

Pharmaceutical Requirements from CCS Through Qualification

A pharmaceutical filter brief is built from the contamination-control strategy outward, not from a filter datasheet inward. The contamination-control strategy sets out how contamination risk is identified and managed across the facility, and the filter’s role is defined by where it sits in that strategy — as part of room air supply, as part of a local protection device, or as part of a barrier system. Until that role is defined, a filter class alone does not say what the filter is actually required to achieve for the product or process it protects.

Room-grade context follows from the contamination-control strategy and determines which qualification activities apply. A filter serving a higher-risk grade carries a different qualification burden than one serving a lower-risk background environment, and the relevant evidence — installed filter integrity testing, airflow and pressure differential verification, airflow visualization, and recovery testing — is not a fixed checklist applied uniformly. It depends on the grade, on what the specific piece of equipment does, on the contamination risk at that point in the process, and on the standards the facility has adopted. A buyer who assumes every grade requires the same qualification package will either over-specify evidence that is not relevant or, more consequentially, omit evidence the facility’s own strategy requires.

One distinction has to be preserved through this entire process: an EU GMP grade is not the same measurement as an ISO airborne-particle class, and one cannot be translated into the other. EU GMP Annex 1 describes a facility-wide contamination-control strategy and the qualification activities tied to it within an EU sterile-manufacturing context; it does not establish a particle-count equivalence with ISO 14644-1. A supplier or buyer who treats a room’s GMP grade as if it automatically implies a specific ISO class is substituting one evidence basis for another. Where a project operates under both frameworks — a GMP grade for the pharmaceutical context and an ISO class for the room’s particle classification — both have to be stated and qualified on their own terms, not merged into a single number.

This sequencing matters because the filter itself is the last decision in this chain, not the first. Once the contamination-control strategy, the room grade, and the applicable qualification lifecycle are established, the filter class, construction, and housing interface can be specified against requirements that are already defined — rather than the filter class being chosen first and the qualification evidence being assembled afterward to match it.

Semiconductor Inputs for Particle, Chemical, and Tool Conditions

A semiconductor filter brief separates into inputs that do not share a common measurement basis, and treating them as one requirement set is where specifications go wrong. Airborne-particle classification describes how clean the air is in terms of particle concentration for the cleanroom, clean zone, or separative device in question. Airborne chemical contamination is a different risk entirely — certain process tools are sensitive to airborne molecular contamination that a particle-rated HEPA or ULPA filter is not designed to remove, regardless of how high its particle efficiency is rated. A buyer who specifies only a particle class for a tool with chemical sensitivity has left a known risk unaddressed in the input sheet.

Tool heat load and recirculation strategy add a further layer that is specific to how semiconductor cleanrooms are typically configured around high-density process tool arrangements. Where tools generate significant heat, the airflow and filtration system has to be sized and arranged with that thermal load in mind, and the recirculation strategy — how air is returned, filtered, and redelivered to the space — interacts directly with filter selection, housing placement, and airflow integration. A filter chosen without reference to the recirculation strategy may satisfy a particle classification in isolation while creating an airflow or thermal interaction problem once installed in the actual room configuration.

Service access is the condition that connects the technical specification to how the facility will actually operate the system over time. If the filter configuration requires change-out from within the cleanroom, that interacts with the particle classification the room is meant to maintain during the service event itself. If the configuration allows access from outside the classified space, the service approach and the housing interface need to reflect that from the outset, not be adapted after installation. This is also where the filter’s role in the broader modular cleanroom structure matters — the same input sheet that specifies particle classification and chemical risk also needs to state how the filter and housing integrate with the room’s airflow and access design, since a semiconductor cleanroom module’s performance depends on these elements working together rather than being specified independently.

None of these four inputs substitutes for another. A complete semiconductor brief states the particle classification, states separately whether chemical contamination risk applies and on what basis, states the tool heat load and recirculation strategy the filtration system has to accommodate, and states the service access the project configuration provides — each as its own line, not folded into a single filter class.

Shared Filter and Housing Data Needed in Both RFQs

RFQ inputDecision it supportsBoundary to keep explicit
Filter classIdentifies the requested filtration classThe acceptance rationale still depends on the intended process risk
DimensionsIdentifies the filter size required for the project configurationDimensions must be stated rather than inferred from the filter class
Airflow and resistance basisAllows airflow and resistance to be reviewed on one stated basisDo not compare values without their operating basis
Seal or housing interfaceChecks the required filter-to-housing interfaceThe interface must be named for the offered configuration
Test evidenceIdentifies the evidence required for evaluation and handoverThe relevant evidence path differs by sector and process risk
Replacement accessChecks whether the planned configuration allows filter replacement accessAccess must reflect the project arrangement

Regardless of which sector’s risk basis applies, a workable RFQ for HEPA or ULPA filtration equipment needs the same category of baseline data — though what justifies each entry still depends on the process behind it. Filter class identifies the filtration performance being requested, but naming a class does not by itself establish that the class is the right one for the application; that judgment still depends on the process risk the earlier sections describe. Two RFQs can specify the same filter class for entirely different reasons, and a supplier reviewing the request needs to know which reason applies to assess whether the class is actually sufficient.

Dimensions have to be stated explicitly rather than assumed from the filter class, because filter class describes performance, not size, and a given class is manufactured in more than one dimensional configuration. Leaving dimensions to be inferred introduces a mismatch risk at the point where the filter has to physically interface with the housing or the room structure, such as a mini pleat HEPA/ULPA air filter sized for a particular ceiling grid or housing frame.

Airflow and resistance figures are only meaningful when their operating basis is stated alongside them — the conditions under which an airflow or resistance value was determined have to travel with the number, because comparing two values without knowing whether they share an operating basis produces a false comparison. The seal or housing interface is a related but separate input: it defines how the filter physically meets its housing, and this has to be named for the specific configuration being offered rather than assumed to be standard, since interface mismatches are a physical coordination problem independent of filter performance.

Test evidence is the point where the sector distinction re-enters even within a shared data set: the evidence appropriate to a pharmaceutical qualification lifecycle is not the same evidence appropriate to a semiconductor particle or chemical-risk brief, so this line item has to be filled in according to the process risk established earlier, not treated as a generic “certificate” request. Replacement access closes the set by tying the filter specification back to how the project’s physical configuration actually allows the filter to be serviced, which depends on the room and housing arrangement the project has adopted rather than on the filter itself.

Evidence Paths That Must Remain Sector-Specific

Evidence pathWhat it supportsWhat it does not establish
EU GMP Annex 1A facility-wide contamination-control strategy and relevant installed filter, airflow, pressure, airflow-visualization, and recovery qualification in an EU sterile-manufacturing contextIt does not create a direct translation from an EU GMP grade to an ISO airborne-particle class; tests and criteria depend on grade, equipment function, risk, and applicable standards
ISO 14644-1:2015Classification of cleanrooms, clean zones, and separative devices by airborne-particle concentrationIt does not equate an ISO class with an EU GMP grade or characterize chemical contamination
ISO 14644-8:2022Assessment and grading of airborne chemical cleanliness for specified substances when airborne chemicals present a process riskIt does not establish surface cleanliness or airborne-particle classification

Each of the three reference frameworks relevant to this comparison answers a different question, and using one to answer another sector’s question is the most consequential error an input sheet can carry forward into a quotation review. EU GMP Annex 1 supports a facility-wide contamination-control strategy and the qualification activities tied to it — installed filter, airflow, pressure, airflow-visualization, and recovery qualification — within an EU sterile-manufacturing context. It does not, on its own terms, create a direct translation from a GMP grade to an ISO airborne-particle class, and the tests and acceptance criteria that apply still depend on the grade, the equipment’s function, the risk involved, and whatever additional standards the project has adopted.

ISO 14644-1 supports classification of cleanrooms, clean zones, and separative devices by airborne-particle concentration. This is the correct reference for a semiconductor particle-classification requirement, and it is also relevant wherever a pharmaceutical room’s particle cleanliness is being classified separately from its GMP grade — but it does not equate its own class designation with a GMP grade, and it says nothing about chemical contamination.

ISO 14644-8 supports assessment and grading of airborne chemical cleanliness for specified substances, and it applies only where airborne chemicals present an actual process risk — this is the semiconductor-relevant case where a tool is sensitive to airborne molecular contamination that a particle filter does not address. It does not establish surface cleanliness, and it does not substitute for an airborne-particle classification.

Where a pharmaceutical project needs to evaluate both GMP grade compliance and room particle cleanliness, both EU GMP Annex 1 and ISO 14644-1 may be relevant, but each has to be assessed on its own criteria rather than treated as confirming the other. Where a semiconductor project needs to evaluate both particle classification and chemical contamination risk, ISO 14644-1 and ISO 14644-8 serve that purpose, but neither finding substitutes for the other even though both may appear in the same project’s acceptance package. The buyer’s task is to confirm which of these frameworks the project’s regulatory or customer requirements actually invoke, and to make sure the evidence requested in the RFQ is drawn from the correct one rather than assumed to be interchangeable because the subject matter — cleanroom air quality — sounds the same across all three.

Acceptance Packages Built Around the Intended Process

Bringing the shared RFQ data and the sector-specific evidence together means the acceptance package has to be assembled around what the equipment is actually protecting, not around a generic filtration checklist applied the same way regardless of process. Where the intended process is pharmaceutical, the acceptance package is organized around the contamination-control strategy and the room-grade qualification lifecycle, with the shared filter and housing data — class, dimensions, airflow basis, interface, evidence, and access — populated according to what that grade and process risk require. Where the intended process is semiconductor, the same shared data set is populated against particle classification, chemical-contamination risk where applicable, tool heat load, and recirculation strategy, with service access reflecting the fab’s operating conditions rather than a pharmaceutical qualification cycle.

This is the stage at which the project information a buyer supplies becomes the basis for how Youth Filter’s configuration and quotation review proceeds, because a request that states the process risk, the applicable room-grade or classification basis, and the shared filter and housing data allows that review to be matched against the correct equipment family and evidence path rather than against assumptions. A request that omits the process risk and states only a filter class leaves the acceptance rationale undefined, regardless of how precisely the class itself is specified.

Where the project’s documentation already identifies a contamination-control strategy and a room grade, the pharmaceutical acceptance path follows from that — the buyer’s remaining task is to confirm which qualification activities apply to the specific equipment and risk involved, as described earlier. Where the project’s documentation already identifies a particle classification and a chemical-risk assessment for the relevant tools, the semiconductor acceptance path follows from that — the buyer’s remaining task is to confirm how recirculation strategy and service access interact with the filtration system before the housing and interface are finalized. In both cases, the acceptance package is not a fixed template; it is built from the process risk outward, with the filter and housing specification as the output of that process rather than its starting point.

Frequently Asked Questions

Q: Can one filter input sheet be used for both pharmaceutical and semiconductor projects?
A: Yes, if it has a shared core plus separate sector-specific sections. Use the common section for filter class, dimensions, airflow and resistance basis, seal or housing interface, test evidence, and replacement access; then record the pharmaceutical contamination-control and qualification context or the semiconductor particle, chemical, tool-load, and recirculation conditions separately.

Q: Should a pharmaceutical project automatically specify HEPA while a semiconductor project specifies ULPA?
A: No. Select the requested filter class from the intended process risk and acceptance basis rather than from the sector name alone. The project brief should also state the required dimensions, operating basis, interface, evidence, and service access so the proposed configuration can be evaluated as a complete system input.

Q: Does meeting an ISO airborne-particle class also address airborne chemical contamination?
A: No. ISO 14644-1 particle classification and ISO 14644-8 chemical cleanliness address different conditions. If specified airborne substances present a process risk, record those substances and the required chemical assessment basis separately from the particle-class requirement.

Q: How should buyers compare quotations that list different airflow or resistance values?
A: First place the values on the same stated operating basis. Then check whether the quotations also use the same filter class, dimensions, and filter-to-housing interface; otherwise, an apparent performance difference may reflect unlike project assumptions rather than a directly comparable offer.

Q: What should be settled before the qualification or handover evidence package is defined?
A: Agree on the intended process, its contamination risks, the applicable room or cleanliness context, and the offered filter and housing configuration. Use those decisions to specify the relevant test evidence, keeping pharmaceutical qualification, airborne-particle classification, and chemical-cleanliness assessment on their own applicable evidence paths.

Last Updated: October 10, 2026

Picture of Barry Liu

Barry Liu

Sales Engineer at Youth Clean Tech specializing in cleanroom filtration systems and contamination control for pharmaceutical, biotech, and laboratory industries. Expertise in pass box systems, effluent decontamination, and helping clients meet ISO, GMP, and FDA compliance requirements. Writes regularly about cleanroom design and industry best practices.

Find Me in Linkedin

Related News

Scroll to Top

Contact Us

Contact us directly: [email protected]

Free to ask

Free to Ask

Contact us directly: [email protected]